Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pharming Group N.V (PHAR) Other Non Operating Income: 2018-2024

Historic Other Non Operating Income for Pharming Group N.V (PHAR) over the last 7 years, with Dec 2024 value amounting to $5.0 million.

  • Pharming Group N.V's Other Non Operating Income was N/A to -$169,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $3.8 million, marking a year-over-year change of. This contributed to the annual value of $5.0 million for FY2024, which is 636.56% up from last year.
  • Latest data reveals that Pharming Group N.V reported Other Non Operating Income of $5.0 million as of FY2024, which was up 636.56% from -$930,000 recorded in FY2023.
  • In the past 5 years, Pharming Group N.V's Other Non Operating Income ranged from a high of $5.0 million in FY2024 and a low of -$1.2 million during FY2022.
  • In the last 3 years, Pharming Group N.V's Other Non Operating Income had a median value of -$930,000 in 2023 and averaged $958,333.
  • Per our database at Business Quant, Pharming Group N.V's Other Non Operating Income tumbled by 1,139.47% in 2022 and then skyrocketed by 636.56% in 2024.
  • Yearly analysis of 5 years shows Pharming Group N.V's Other Non Operating Income stood at $69,000 in 2020, then spiked by 65.22% to $114,000 in 2021, then crashed by 1,139.47% to -$1.2 million in 2022, then increased by 21.52% to -$930,000 in 2023, then soared by 636.56% to $5.0 million in 2024.